MYD88 and ovarian cancer: In order to discern a possible relationship between MAD2 and TLR4-MyD88 signalling, transfection experiments were performed initially in both A2780 (MyD88 null) and SKOV-3 (MyD88 positive) ovarian cancer cells (Fig 1).